Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - rosuvastatinum, ezetimibum - filmtabletten - filmtablette: rosuvastatinum 20 mg ut rosuvastatinum calcicum, ezetimibum 10.00 mg, amylum pregelificatum, cellulosum microcristallinum, megluminum, calcii hydrogenophosphas dihydricus, crospovidonum, silica colloidalis anhydrica, natrii stearylis fumaras, mannitolum, e 320, natrii laurilsulfas, carmellosum natricum conexum, povidonum k 30, e 172 (rubrum), magnesii stearas, Überzug: hypromellosum, titanii dioxidum, macrogolum, e 172 (rubrum), pro compresso obducto corresp. natrium 3.09 mg. - reduktion der serumcholesterinkonzentration - synthetika

Europäische Union - Deutsch - EMA (European Medicines Agency)

mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antithrombotische mittel - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - lenalidomidum - hartkapseln - lenalidomidum 2.50 mg, amylum pregelificatum, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, kapselhülle: e 172 (flavum), titanii dioxidum, e 132, gelatina, drucktinte: lacca, propylenglycolum, e 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.411 mg. - onkologikum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - lenalidomidum - hartkapseln - lenalidomidum 5.0 mg, amylum pregelificatum, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, kapselhülle: titanii dioxidum, gelatina, drucktinte: lacca, propylenglycolum, e 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.807 mg. - onkologikum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - lenalidomidum - hartkapseln - lenalidomidum 7.5 mg, amylum pregelificatum, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, kapselhülle: e 172 (flavum), titanii dioxidum, e 172 (nigrum), gelatina, drucktinte: lacca, propylenglycolum, e 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.506 mg. - onkologikum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - lenalidomidum - hartkapseln - lenalidomidum 10.0 mg, amylum pregelificatum, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, kapselhülle: e 172 (flavum), titanii dioxidum, e 172 (nigrum), e 132, gelatina, drucktinte: lacca, propylenglycolum, e 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 1.588 mg. - onkologikum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - lenalidomidum - hartkapseln - lenalidomidum 15.0 mg, amylum pregelificatum, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, kapselhülle: titanii dioxidum, gelatina, drucktinte: lacca, e 172 (rubrum), propylenglycolum, simeticonum, pro capsula corresp. natrium 0.986 mg. - onkologikum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - lenalidomidum - hartkapseln - lenalidomidum 20.0 mg, amylum pregelificatum, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, kapselhülle: e 172 (flavum), titanii dioxidum, e 132, gelatina, drucktinte: lacca, e 172 (rubrum), propylenglycolum, simeticonum, pro capsula corresp. natrium 1.282 mg. - onkologikum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - lenalidomidum - hartkapseln - lenalidomidum 25.0 mg, amylum pregelificatum, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, kapselhülle: titanii dioxidum, gelatina, drucktinte: lacca, propylenglycolum, e 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 1.579 mg. - onkologikum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - letrozolum - filmtabletten - letrozolum 2.5 mg, lactosum monohydricum 61.5 mg, cellulosum microcristallinum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium 0.14-0.21 mg, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, talcum, macrogolum 8000, e 171, e 172 (flavum) pro compresso obducto. - cytostatikum - synthetika